US Edition
Guyana acquires low-cost, brand name highly effective HPV vaccine to boost prevention of cervical cancer
Summary by Demerara Waves
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Guyana acquires low-cost, brand name highly effective HPV vaccine to boost prevention of cervical cancer
Last Updated on Thursday, 24 July 2025, 19:41 by Writer Guyana has acquired Merck-made 9-valiant HPV (human papilloma virus) vaccines at a very low cost through a deal negotiated by the Pan-American Health Organisation (PAHO), according to Health Minister Dr Frank Anthony. The HPV virus is responsible for most cervical cancers. The virus can also ...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
